Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
European Journal of Gynaecological Oncology|January 1, 1996
Tumor-associated urokinase-type plasminogen activator: significance in breast cancerE A Torre, R A FulcoJournal of Chemotherapy (Florence, Italy)|February 1, 1997
The erbB 2 oncogene and chemotherapy: a mini-reviewE A Torre, V Salimbeni, R A FulcoMinerva Medica|April 30, 1998
Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancerR A Fulco, M Petix, V Salimbeni, et al.Journal of Endocrinological Investigation|April 10, 2019
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trendP Malandrino, D Tumino, M Russo, et al.Anticancer Research|May 1, 1988
Serial determination of platinum, protein content and free sulfhydryl levels in plasma of patients treated with cisplatin or carboplatinF Tosetti, M Rocco, R A Fulco, et al.Anticancer Research|November 1, 1990
Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemiaR A Fulco, M Vannozzi, P Collecchi, et al.Journal of the National Cancer Institute|April 18, 1990
Improved therapeutic index of cisplatin by procaine hydrochlorideM Esposito, R A Fulco, P Collecchi, et al.Cancer|September 1, 1991
Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastasesD Civalleri, M Esposito, R A Fulco, et al.Anticancer Research|November 1, 1992
Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochlorideS Cafaggi, M Esposito, B Parodi, et al.Pageof 2